Published in J Virol on December 01, 1990
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (1995) 2.68
Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A (1994) 2.47
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ Health Perspect (1993) 2.30
Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol (1992) 2.04
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol (1997) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol (2009) 1.79
Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol (2002) 1.78
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol (2001) 1.42
Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol (1996) 1.35
A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci U S A (1996) 1.18
Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol (2008) 1.17
Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore. J Virol (2009) 1.16
Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J Virol (2010) 1.12
Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol (2001) 1.11
Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol (2000) 1.08
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res (1996) 1.07
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology (2009) 1.01
The hepatitis B virus X protein transactivates viral core gene expression in vivo. J Virol (1999) 0.98
Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol (2009) 0.98
Mouse models in liver cancer research: a review of current literature. World J Gastroenterol (2008) 0.98
The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol (2011) 0.96
Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the Sleeping Beauty transposon system. Hepatology (2011) 0.95
Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol (2002) 0.95
Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology (2012) 0.92
Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res (2008) 0.92
Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury. PLoS One (2011) 0.87
Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J Gastroenterol (2002) 0.85
Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene. World J Gastroenterol (1998) 0.84
The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. Virus Res (2010) 0.84
Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res Int (2014) 0.84
Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis. Oncogene (2015) 0.81
Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World J Gastroenterol (2016) 0.81
Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice. World J Gastroenterol (2006) 0.78
Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut Liver (2007) 0.77
Activation of signal transduction pathways during hepatic oncogenesis. Cancer Lett (2015) 0.77
Hepatitis B virus X induces inflammation and cancer in mice liver through dysregulation of cytoskeletal remodeling and lipid metabolism. Oncotarget (2016) 0.77
Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis. World J Hepatol (2015) 0.75
Viral hepatitis. Gut (1991) 0.75
Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis. Hepatology (2016) 0.75
Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and HCC: It's complicated. Hepatology (2016) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
The hepatitis B virus. Nature (1985) 8.71
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (1979) 6.76
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (1990) 4.10
The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science (1987) 4.01
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell (1989) 3.60
Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell (1984) 3.56
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol (1988) 3.04
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science (1985) 2.47
Transcriptional trans-activating function of hepatitis B virus. J Virol (1987) 2.46
Transgenic mice as probes into complex systems. Science (1989) 2.34
Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.24
Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol (1989) 2.21
Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci U S A (1989) 2.10
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene (1988) 2.02
Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci U S A (1987) 1.88
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J (1990) 1.84
Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A (1989) 1.77
Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science (1985) 1.70
Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science (1985) 1.63
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res (1987) 1.51
Ground squirrel hepatitis virus DNA: molecular cloning and comparison with hepatitis B virus DNA. J Virol (1981) 1.48
The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J (1990) 1.45
The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J (1985) 1.45
The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res (1989) 1.45
Hepatitis B virus polypeptide X: expression in Escherichia coli and identification of specific antibodies in sera from hepatitis B virus-infected humans. J Virol (1986) 1.35
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A (1989) 1.34
Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest (1988) 1.34
Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J Virol (1988) 1.19
Modification of simian virus 40 large tumor antigen by glycosylation. Virology (1985) 1.18
Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci U S A (1987) 1.15
Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet (1988) 1.15
Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol (1988) 1.07
Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology (1987) 1.05
trans-activation by the hepatitis B virus X protein shows cell-type specificity. Virology (1989) 1.05
Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology (1989) 0.98
Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice. DNA (1989) 0.96
Transgenic mice--a gold mine for furthering knowledge in pathobiology. Lab Invest (1988) 0.92
Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. Cancer Res (1984) 0.92
Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. J Virol (1989) 0.91
Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity. J Virol (1990) 0.91
Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology (1990) 0.90
X antigen polypeptides in the sera of hepatitis B virus-infected patients. Virology (1990) 0.85
Expression of the X gene of hepatitis B virus. J Med Virol (1986) 0.85
Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene. Virology (1988) 0.84
Low incidence and high titers of antibodies to hepatitis B virus X-protein in sera of Chinese patients with hepatocellular carcinoma. J Med Virol (1988) 0.83
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science (2001) 7.17
Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68
Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry (1985) 4.78
alpha 1-antitrypsin deficiency detection by direct analysis of the mutation in the gene. Nature (1983) 4.38
The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis (1985) 4.08
Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet (1985) 3.77
Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry (1984) 3.75
Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (1992) 3.54
Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29
Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature (1986) 3.29
Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther (1993) 3.02
The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98
Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature (1984) 2.82
Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet (1987) 2.73
DNA sequencing with dye-labeled terminators and T7 DNA polymerase: effect of dyes and dNTPs on incorporation of dye-terminators and probability analysis of termination fragments. Nucleic Acids Res (1992) 2.71
Complete nucleotide sequence of the chicken chromosomal ovalbumin gene and its biological significance. Biochemistry (1981) 2.67
Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet (1988) 2.67
Regional mapping of the phenylalanine hydroxylase gene and the phenylketonuria locus in the human genome. Proc Natl Acad Sci U S A (1985) 2.58
The ovalbumin gene: alleles created by mutations in the intervening sequences of the natural gene. Cell (1979) 2.56
A sensitive and rapid method for recombinant phage screening. Methods Enzymol (1979) 2.52
Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry (1986) 2.49
CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol (1997) 2.44
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44
Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct. Biochemistry (1975) 2.42
An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature (1987) 2.37
The importance of quadriceps and hamstring muscle loading on knee kinematics and in-situ forces in the ACL. J Biomech (1999) 2.31
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
Physical and chemical characterization of purified ovalbumin messenger RNA. J Biol Chem (1975) 2.28
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27
Definition of 5' and 3' structural boundaries of the chromatin domain containing the ovalbumin multigene family. J Biol Chem (1982) 2.22
Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A (1991) 2.19
Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res (1997) 2.16
Influences of flexor sheath continuity and early motion on tendon healing in dogs. J Hand Surg Am (1990) 2.14
A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum. J Biol Chem (1988) 2.11
The synthesis and properties of the complete complementary DNA transcript of ovalbumin mRNA. Biochemistry (1976) 2.08
DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature (1985) 2.03
Subcellular Localization of simian virus 40 large tumor antigen. J Virol (1979) 2.03
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
The chick ovomucoid gene contains at least six intervening sequences. Nature (1979) 2.01
A new method for determining cross-sectional shape and area of soft tissues. J Biomech Eng (1988) 1.96
Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochim Biophys Acta (1975) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther (1992) 1.92
Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A (1981) 1.91
Assignment of the alpha 1-antitrypsin gene and a sequence-related gene to human chromosome 14 by molecular hybridization. Am J Hum Genet (1983) 1.91
The development of mature gait. J Bone Joint Surg Am (1980) 1.91
Effects of postmortem storage by freezing on ligament tensile behavior. J Biomech (1986) 1.89
Nascent chicken ovalbumin contains the functional equivalent of a signal sequence. J Cell Biol (1978) 1.88
GT to AT transition at a splice donor site causes skipping of the preceding exon in phenylketonuria. Nucleic Acids Res (1987) 1.86
Polymerase chain reaction amplification from dried blood spots on Guthrie cards. Lancet (1990) 1.86
Müllerian-inhibiting substance function during mammalian sexual development. Cell (1994) 1.85
Effects of immobilization on joints. Clin Orthop Relat Res (1987) 1.84
Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79
The natural ovalbumin gene contains seven intervening sequences. Nature (1978) 1.79
Identification of multiple species of calmodulin messenger RNA using a full length complementary DNA. J Biol Chem (1983) 1.79
Ovalbumin is synthesized in mouse cells transformed with the natural chicken ovalbumin gene. Proc Natl Acad Sci U S A (1980) 1.77
Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol (1989) 1.76
Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev (1996) 1.75
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest (1989) 1.72
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.70
Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes. Nature (1982) 1.70
Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA. Proc Natl Acad Sci U S A (1982) 1.69
Molecular cloning of ovomucoid gene sequences from partially purified ovomucoid messenger RNA. Biochemistry (1978) 1.67
Regulation of casein messenger RNA during the development of the rat mammary gland. Biochemistry (1975) 1.66
Prenatal diagnosis of classic phenylketonuria by DNA analysis. Lancet (1985) 1.64
Chitinase gene expression during mycoparasitic interaction of Trichoderma harzianum with its host. Fungal Genet Biol (1999) 1.64
Nonlinear material properties of intact cornea and sclera. Exp Eye Res (1972) 1.63
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
The ovalbumin gene: cloning and molecular organization of the entire natural gene. Proc Natl Acad Sci U S A (1979) 1.61
Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A (1994) 1.60
Pneumonic plague in monkeys. An electron microscopic study. Am J Pathol (1969) 1.60
Full-length cDNA for rabbit tryptophan hydroxylase: functional domains and evolution of aromatic amino acid hydroxylases. Proc Natl Acad Sci U S A (1987) 1.59
DNA sequence for cloned cDNA for murine amelogenin reveal the amino acid sequence for enamel-specific protein. Biochem Biophys Res Commun (1985) 1.57
Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice. Cell Growth Differ (1997) 1.57
Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr (1992) 1.56
Isolation and sequence characterization of a cDNA clone of human antithrombin III. Proc Natl Acad Sci U S A (1983) 1.56
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
In situ forces in the anterior cruciate ligament and its bundles in response to anterior tibial loads. J Orthop Res (1997) 1.55
Cloning large segments of genomic DNA using cosmid vectors. Methods Enzymol (1987) 1.55
Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res (1987) 1.51
Phenylalanine hydroxylase deficiency caused by a single base substitution in an exon of the human phenylalanine hydroxylase gene. Biochemistry (1988) 1.50
Effects of early intermittent passive mobilization on healing canine flexor tendons. J Hand Surg Am (1982) 1.50
Point mutagenesis of the ovalbumin gene promoter sequence and its effect on in vitro transcription. J Biol Chem (1982) 1.50
Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther (1994) 1.50
Genes from mycoparasitic fungi as a source for improving plant resistance to fungal pathogens. Proc Natl Acad Sci U S A (1998) 1.50
The forces in the anterior cruciate ligament and knee kinematics during a simulated pivot shift test: A human cadaveric study using robotic technology. Arthroscopy (2000) 1.49
Tensile and viscoelastic properties of human patellar tendon. J Orthop Res (1994) 1.49